A recent NYT magazine article on “plumpynut” the ready-to-use therapeutic food was published under much controversy over its proper usage, its price tag and its patent (owned by a french company) thus limiting its coverage and accessibility. Our response is coming to the Huffington post and will post here as well as soon as it is out.